 This clinical trial will be a comparison of diagnostic and imaging equivalency of 99mTc Pertechnetate intravenous injection labeled with commercial MDP kits produced by a non-fission sourcedsolvent generator and a nuclear reactorcolumn sourced generator. Each oncologic participant acts as their own control to reduce error variance. 